Additional medication options added
TERRE HAUTE – WIN Recovery, a certified opioid treatment center operated by Hamilton Center, Inc., has expanded its services and is now prescribing Suboxone and Buprenorphine in addition to Methadone for those seeking medication-assisted treatment (MAT) for opioid use disorder.
WIN Recovery provides MAT, health, social, and rehabilitation services that relieve withdrawal symptoms, reduce physiological cravings, and allow normalization of the body’s functions. While Methadone has been available for over 50 years and has been confirmed effective for opioid dependence, both Suboxone and Buprenorphine are effective in treating Opioid Use Disorder. The addition of Suboxone and Buprenorphine will allow WIN Recovery to offer additional treatment options for those patients who require medications other than Methadone for treating Opioid Use Disorder.
The Substance Abuse and Mental Health Services Administration reports that in 2022, 48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year. Additionally, in 2021, 94% of people aged 12 or older with a substance use disorder did not receive any treatment.
“WIN Recovery works each day to eliminate the barriers that might be keeping someone with substance use disorder from pursuing treatment,” said Molly Funk, Executive Director of Addiction Services at Hamilton Center.
“WIN Recovery is now uniquely positioned to treat anyone living with opioid use disorder due to offering all major modes of MAT in one clinical setting, while also providing behavioral health and community support along with wraparound services.”
Additionally, WIN Recovery has onsite navigators to help with insurance and/or funding concerns.
WIN Recovery provides comprehensive treatment for adults (age 18 or older) who are struggling with opioid use disorder. The program provides daily medication coupled with individual and group counseling and case management services to treat each patient’s unique needs.
